Acumen Pharmaceuticals (ABOS)'s 30-day implied volatility (IV30) was 64.6% at the close on October 22, 2026, down from 241.6% the day before, against a 52-week range of 51.1% to 241.6%. Its 20-day historical volatility was 88.2%.
Data as of October 22, 2026.